Astellas Exec Talks Dealmaking and Pipeline Strategy in Cancer, Gene Therapy & More

Astellas Pharma still looks to grow in cancer with a pipeline that includes internally developed programs that could stand out in oncology. But the drugmaker sees additional growth opportunities in ophthalmology and neuromuscular disorders, Chief Medical Officer Tadaaki Taniguci said. The post Astellas Exec Talks Dealmaking and Pipeline Strategy in Cancer, Gene Therapy & More…

Read More

Hospitales dicen que no rechazarán pacientes, mientras los estados se posicionan sobre inmigración

California está aconsejando a los proveedores de atención médica que no pongan el estatus migratorio de los pacientes en las facturas y los registros médicos, y enfatiza que no tienen que ayudar a los agentes federales durante arrestos. Algunos hospitales y clínicas de Massachusetts están colgando carteles sobre derechos de privacidad en las salas de…

Read More

Bridging Clinical Research Gaps: How Site Augmentation Enhances Trial Success

Understanding how site augmentation services could be leveraged to overcome challenges is not the responsibility of one entity. The most creative and effective solutions arise from collaboration among all stakeholders — sponsors, CROs, service providers, and research sites. The post Bridging Clinical Research Gaps: How Site Augmentation Enhances Trial Success appeared first on MedCity News.

Read More

Trump’s Early Health Moves Signal Intent To Erase Biden’s Legacy. What’s Next is Unclear.

President Donald Trump’s early actions on health care signal his likely intention to wipe away some Biden-era programs to lower drug costs and expand coverage under public insurance programs. The orders he issued soon after reentering the White House have policymakers, health care executives, and patient advocates trying to read the tea leaves to determine…

Read More